共 18 条
Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus
被引:47
作者:

Carter, AM
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England

Bennett, CE
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England

Bostock, JA
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England

Grant, PJ
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England
机构:
[1] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England
关键词:
Type 2 diabetes mellitus;
metformin;
C-reactive protein;
complement C3;
D O I:
10.1111/j.1464-5491.2005.01632.x
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Aims To determine the influence of metformin treatment on plasma C-reactive protein (CRP) and complement factor C3. Methods A double-blind, placebo-controlled trial of metformin in patients with poorly controlled Type 2 diabetes mellitus and body mass index > 25 kg/m(2). CRP and C3 were analysed in stored plasma samples by in-house ELISAs. Patients attended two baseline visits before randomization and subsequently attended at 3, 6, 12 and 24 weeks post randomization. All patients gave informed consent according to a protocol approved by the Leeds Teaching Hospitals Research Ethics Committee. Results Baseline CRP in the patients randomized to placebo [1.33 (0.79, 2.25) mg/l] and metformin [1.24 (0.89, 1.71) mg/l] were similar (P = 0.8). Baseline CRP correlated with baseline C3 (r = 0.366) and HbA(1c) (r = 0.327). The difference in ratios of CRP levels at each visit to baseline between placebo- (n = 16) and metformin-treated (n = 26) subjects was significantly different at the 12-week (P = 0.002) and 24-week (P = 0.03) visits. The difference in CRP ratios between the two treatment groups remained significant after accounting for glycaemic control at both visits (P = 0.001 and P = 0.003, respectively). Baseline C3 was correlated with CRP. Baseline C3 was lower in the placebo-treated group [0.97 (0.88, 1.05) mg/ml] compared with the metformin-treated group [1.09 (1.02, 1.17) mg/ml, P = 0.03]. There was no difference in the mean change in C3 at any visit from baseline between placebo- and metformin-treated groups. Conclusion Metformin may have a specific interaction with mechanisms involved in CRP synthesis or secretion, not directly related to improved insulin sensitivity and dampening of chronic inflammation.
引用
收藏
页码:1282 / 1284
页数:3
相关论文
共 18 条
[1]
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes
[J].
Chu, NV
;
Caulfield, M
;
Kong, APS
;
Mudaliar, SR
;
Kim, DD
;
Reitz, R
;
Armstrong, D
;
Henry, RR
;
Baxi, S
;
Reaven, PD
;
Deutsch, R
.
DIABETES CARE,
2002, 25 (03)
:542-549

Chu, NV
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Caulfield, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Kong, APS
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Mudaliar, SR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Kim, DD
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Reitz, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Armstrong, D
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Henry, RR
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Baxi, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Reaven, PD
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA

Deutsch, R
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif San Diego, VA San Diego Healthcare Syst, Dept Endocrinol & Metab, San Diego, CA 92161 USA
[2]
EFFICACY OF METFORMIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
[J].
DEFRONZO, RA
;
GOODMAN, AM
;
ABELOVE, W
;
REID, E
;
PITA, J
;
CALLAHAN, M
;
JOHNSON, D
;
PELAYO, E
;
PUGH, J
;
SHANK, M
;
GARZA, P
;
HAAG, B
;
KORFF, J
;
ANGELO, A
;
IZENSTEIN, B
;
VANDERLEEDEN, M
;
CATHCART, H
;
TIERNEY, M
;
BIGGS, D
;
KARAM, J
;
NOLTE, M
;
GAVIN, L
;
ELDER, MA
;
CORBOY, J
;
THWAITE, D
;
WONG, S
;
DAVIDSON, M
;
PETERS, A
;
DUNCAN, T
;
KERCHER, S
;
FISCHER, J
;
KIPNES, M
;
RADNICK, BJ
;
ROURA, M
;
ROQUE, J
;
MONTGOMERY, C
;
COLLUM, P
;
RUST, M
;
POHL, S
;
PFEIFER, M
;
ALLWEISS, P
;
LEICHTER, S
;
LEACH, P
;
GALLINA, D
;
MUSEY, V
;
BERKOWITZ, K
;
EASTMAN, R
;
TAYLOR, T
;
DELAPENA, MS
;
ZAWADSKI, J
.
NEW ENGLAND JOURNAL OF MEDICINE,
1995, 333 (09)
:541-549

DEFRONZO, RA
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

GOODMAN, AM
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ABELOVE, W
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

REID, E
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

PITA, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

CALLAHAN, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

JOHNSON, D
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

PELAYO, E
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

PUGH, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

SHANK, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

GARZA, P
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

HAAG, B
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

KORFF, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ANGELO, A
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

IZENSTEIN, B
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

VANDERLEEDEN, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

CATHCART, H
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

TIERNEY, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

BIGGS, D
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

KARAM, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

NOLTE, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

GAVIN, L
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ELDER, MA
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

CORBOY, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

THWAITE, D
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

WONG, S
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

DAVIDSON, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

PETERS, A
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

DUNCAN, T
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

KERCHER, S
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

FISCHER, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

KIPNES, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

RADNICK, BJ
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ROURA, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ROQUE, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

MONTGOMERY, C
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

COLLUM, P
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

RUST, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

POHL, S
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

PFEIFER, M
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ALLWEISS, P
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

LEICHTER, S
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

LEACH, P
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

GALLINA, D
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

MUSEY, V
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

BERKOWITZ, K
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

EASTMAN, R
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

TAYLOR, T
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

DELAPENA, MS
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA

ZAWADSKI, J
论文数: 0 引用数: 0
h-index: 0
机构: LIPHA PHARMACEUT, NEW YORK, NY USA
[3]
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes
[J].
Ebeling, P
;
Teppo, AM
;
Koistinen, HA
;
Viikari, J
;
Rönnemaa, T
;
Nissén, M
;
Bergkulla, S
;
Salmela, P
;
Saltevo, J
;
Koivisto, VA
.
DIABETOLOGIA,
1999, 42 (12)
:1433-1438

Ebeling, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Teppo, AM
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Koistinen, HA
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Viikari, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Rönnemaa, T
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Nissén, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Bergkulla, S
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Salmela, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Saltevo, J
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland

Koivisto, VA
论文数: 0 引用数: 0
h-index: 0
机构: Univ Helsinki, Cent Hosp, Dept Med, Div Internal Med & Geriatr, FIN-00029 HYKS, Finland
[4]
The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes
[J].
Grant, PJ
.
DIABETES CARE,
1996, 19 (01)
:64-66

Grant, PJ
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV LEEDS,RES SCH MED,DIABET & THROMBOSIS RES GRP,LEEDS,W YORKSHIRE,ENGLAND UNIV LEEDS,RES SCH MED,DIABET & THROMBOSIS RES GRP,LEEDS,W YORKSHIRE,ENGLAND
[5]
Metformin: An update
[J].
Kirpichnikov, D
;
McFarlane, SI
;
Sowers, JR
.
ANNALS OF INTERNAL MEDICINE,
2002, 137 (01)
:25-33

Kirpichnikov, D
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA

McFarlane, SI
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA

Sowers, JR
论文数: 0 引用数: 0
h-index: 0
机构: SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[6]
Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction
[J].
Laine, P
;
Pentikäinen, MO
;
Würzner, R
;
Penttilä, A
;
Paavonen, T
;
Meri, S
;
Kovanen, PT
.
AMERICAN JOURNAL OF CARDIOLOGY,
2002, 90 (04)
:404-+

Laine, P
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Pentikäinen, MO
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Würzner, R
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Penttilä, A
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Paavonen, T
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Meri, S
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland

Kovanen, PT
论文数: 0 引用数: 0
h-index: 0
机构: Wihuri Res Inst, FIN-00140 Helsinki, Finland
[7]
Metformin improves hemodynamic and rheological responses to L-arginine in MIDDM patients
[J].
Marfella, R
;
Acampora, R
;
Verrazzo, G
;
Ziccardi, P
;
DeRosa, N
;
Giunta, R
;
Giugliano, D
.
DIABETES CARE,
1996, 19 (09)
:934-939

Marfella, R
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

Acampora, R
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

Verrazzo, G
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

Ziccardi, P
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

DeRosa, N
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

Giunta, R
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY

Giugliano, D
论文数: 0 引用数: 0
h-index: 0
机构:
UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY UNIV NAPLES 2,DEPT GERIATR & METAB DIS,NAPLES,ITALY
[8]
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome
[J].
Morin-Papunen, L
;
Rautio, K
;
Ruokonen, A
;
Hedberg, P
;
Puukka, M
;
Tapanainen, JS
.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,
2003, 88 (10)
:4649-4654

Morin-Papunen, L
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland

Rautio, K
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland

Ruokonen, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland

Hedberg, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland

Puukka, M
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland

Tapanainen, JS
论文数: 0 引用数: 0
h-index: 0
机构: Univ Oulu, Oulu Univ Hosp, Dept Obstet & Gynecol, FIN-90014 Oulu, Finland
[9]
ASSOCIATION OF SERUM C3 LEVELS WITH THE RISK OF MYOCARDIAL-INFARCTION
[J].
MUSCARI, A
;
BOZZOLI, C
;
PUDDU, GM
;
SANGIORGI, Z
;
DORMI, A
;
ROVINETTI, C
;
DESCOVICH, GC
;
PUDDU, P
.
AMERICAN JOURNAL OF MEDICINE,
1995, 98 (04)
:357-364

MUSCARI, A
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

BOZZOLI, C
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

PUDDU, GM
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

SANGIORGI, Z
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

DORMI, A
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

ROVINETTI, C
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

DESCOVICH, GC
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY

PUDDU, P
论文数: 0 引用数: 0
h-index: 0
机构: UNIV BOLOGNA,CTR STUDY ARTERIOSCLEROSIS & DYSMETAB DIS,INST MED PATHOL & OCCUPAT MED,I-40138 BOLOGNA,ITALY
[10]
Short term effect of atorvastatin and vitamin E on serum levels of C3, a sensitive marker of the risk of myocardial infarction in men
[J].
Muscari, A
;
Bastagli, L
;
Poggiopollini, G
;
Tomassetti, V
;
Massarelli, G
;
Boni, P
;
Puddu, P
.
CARDIOVASCULAR DRUGS AND THERAPY,
2001, 15 (05)
:453-458

Muscari, A
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Bastagli, L
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Poggiopollini, G
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Tomassetti, V
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Massarelli, G
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Boni, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy

Puddu, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Bologna, S Orsola M Malpighi Hosp, Dept Internal Med, I-40138 Bologna, Italy